My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 519

    1.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

    Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

    Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

    4.

    Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.

    Tam FW, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH.

    Cytokine. 2009 Jul;47(1):37-42. Epub 2009 May 5.PMID: 19409809 [PubMed - indexed for MEDLINE]Related articles

    5.

    Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.

    Ellis D, Forrest KY, Erbey J, Orchard TJ.

    Clin Chem. 1998 May;44(5):950-6.PMID: 9590367 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

    Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R.

    Diabetes Care. 2004 May;27(5):1164-70.PMID: 15111539 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.

    Agardh CD, Agardh E, Torffvit O.

    Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21.PMID: 9179466 [PubMed - indexed for MEDLINE]Related articles

    8.

    Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.

    Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.

    J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. Epub 2008 Apr 16.PMID: 18413184 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increased collagen IV excretion in diabetes. A marker of compromised filtration function.

    Cohen MP, Lautenslager GT, Shearman CW.

    Diabetes Care. 2001 May;24(5):914-8.PMID: 11347754 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.

    Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O.

    Diabet Med. 2001 Feb;18(2):121-5.PMID: 11251675 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.

    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.

    Diabetes Res Clin Pract. 2004 Aug;65(2):167-73.PMID: 15223229 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy.

    Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B.

    Diabet Med. 2000 Sep;17(9):644-9.PMID: 11051283 [PubMed - indexed for MEDLINE]Related articles

    13.

    Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore.

    Hong CY, Hughes K, Chia KS, Ng V, Ling SL.

    Diabetes Care. 2003 Feb;26(2):338-42.PMID: 12547859 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Serum type IV collagen in diabetic patients at risk for nephropathy.

    Cohen MP, Shearman CW, Lautenslager GT.

    Diabetes Care. 2001 Aug;24(8):1324-7.PMID: 11473064 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.

    Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS.

    Diabetes Care. 1995 Jul;18(7):1013-6.PMID: 7555533 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation]

    Jungmann E, Carlberg C, Schallmayer M, Schumm-Draeger PM.

    Med Klin (Munich). 1995 Jul 15;90(7):383-9. German. PMID: 7675002 [PubMed - indexed for MEDLINE]Related articles

    17.

    Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.

    Ibrahim S, Rashed L.

    Saudi Med J. 2007 Apr;28(4):519-23.PMID: 17457470 [PubMed - indexed for MEDLINE]Related articles

    18.

    Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.

    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.

    Diabet Med. 2004 Jun;21(6):545-51.PMID: 15154937 [PubMed - indexed for MEDLINE]Related articles

    19.

    Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria.

    Turk N, Mornar A, Mrzljak V, Turk Z.

    Diabetes Metab. 2004 Apr;30(2):187-92.PMID: 15223992 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.

    Nakamura T, Ushiyama C, Suzuki S, Shimada N, Sekizuka K, Ebihara L, Koide H.

    Diabet Med. 2001 Apr;18(4):308-13.PMID: 11437862 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity